-
Subject Areas on Research
-
A functional tethered ligand thrombin receptor is present on human hematopoietic progenitor cells.
-
A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.
-
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.
-
A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
-
A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients.
-
Absence of phosphatidylinositol (PI)-linked proteins in a very early human multipotential haematopoietic marrow cell.
-
Aging is not associated with bone marrow-resident progenitor cell depletion.
-
Alteration of the CD34+ Tf-1 beta cell line profile in response to long-term exposure to IL-15.
-
Alterations in colonic mucosal vessels in patients with cirrhosis and noncirrhotic portal hypertension.
-
Amendment to Clinical Research Project. Project 90-C-195. April 1, 1993. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with autologous lymphocytes transduced with a human ADA gene.
-
An effective strategy for decontamination, ex vivo expansion, and storage of human fetal liver hematopoietic stem cells.
-
Antibody-Armed Platelets for the Regenerative Targeting of Endogenous Stem Cells.
-
Apheresis. New opportunities.
-
Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia.
-
Auto-SCT for AML in second remission: CALGB study 9620.
-
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study.
-
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.
-
CD34 and dural fibroblasts: the relationship to solitary fibrous tumor and meningioma.
-
CD34 expression in desmoplastic melanoma.
-
CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.
-
CD34+ cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina.
-
CD34+CD38-lin- cord blood cells develop into dendritic cells in human thymic stromal monolayers and thymic nodules.
-
Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report.
-
Characterization of multiple CD34+ cell populations in cord blood.
-
Circulating CD34+ cell counts are predictive of CD34+ peripheral blood progenitor cell yields.
-
Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity.
-
Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations.
-
Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells.
-
Constitutive Stat3 activation alters behavior of hair follicle stem and progenitor cell populations.
-
Cutaneous metastasis of SMARCA4-deficient thoracic sarcoma: A diagnostic dilemma with therapeutic implications.
-
Cutaneous wound healing is impaired in hemophilia B.
-
Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma.
-
Depletion of circulating progenitor cells precedes overt diabetes: a substudy from the VA enhanced fitness trial.
-
Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry.
-
Development and validation of a rapid, aldehyde dehydrogenase bright-based cord blood potency assay.
-
Diagnosis of posttransplant granulocytic sarcoma by fine-needle aspiration cytology and flow cytometry.
-
Differential effects of nitric oxide on erythroid and myeloid colony growth from CD34+ human bone marrow cells.
-
Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors ("hematogones") and B lymphoblastic leukemia blasts.
-
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.
-
Effects of IL-1 on hematopoietic progenitors after myelosuppressive chemoradiotherapy.
-
Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors.
-
Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency.
-
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
-
Ex vivo expansion of murine and human hematopoietic stem cells.
-
Expression of protooncogene c-myb in normal human hematopoietic cells.
-
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma.
-
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.
-
Gene therapy for immunodeficiency due to adenosine deaminase deficiency.
-
Getting Back to Normal: Can Enhanced Regeneration Maintain Health?
-
Gαq and hyper-phosphorylated ERK expression in Sturge-Weber syndrome leptomeningeal blood vessel endothelial cells.
-
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.
-
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).
-
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.
-
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.
-
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.
-
Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU.
-
Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension.
-
Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
-
Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI.
-
Increased numbers of total nucleated and CD34+ cells in blood group O cord blood: an analysis of neonatal innate factors in the Korean population.
-
Increased transmigration of G-CSF-mobilized peripheral blood CD34+ cells after overnight storage at 37 degrees C.
-
Intradialytic hypertension and its association with endothelial cell dysfunction.
-
Intramyocardial, autologous CD34+ cell therapy for refractory angina.
-
Intraretinal neovascularization in diabetic retinopathy.
-
Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy.
-
Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome.
-
Lack of circulating megakaryoblasts in newborn peripheral blood: development and validation of a sensitive flow cytometric detection method.
-
Large-scale mobilization and isolation of CD34+ cells from normal donors.
-
Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells.
-
Magnetic resonance imaging captures the biology of ductal carcinoma in situ.
-
Manufacture of Autologous CD34+ Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune Diseases.
-
Microvascular inflammation in renal allograft biopsies assessed by endothelial and leukocyte co-immunostain: a retrospective study on reproducibility and clinical/prognostic correlates.
-
Mobilization and collection of peripheral blood CD34+ cells from patients with Fanconi anemia.
-
Mobilization of dendritic cells in cancer patients treated with granulocyte colony-stimulating factor and chemotherapy.
-
Molecular profile and partial functional analysis of novel endothelial cell-derived growth factors that regulate hematopoiesis.
-
Multi-site evaluation of the BD Stem Cell Enumeration Kit for CD34(+) cell enumeration on the BD FACSCanto II and BD FACSCalibur flow cytometers.
-
Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells.
-
Myeloblast phenotypic changes in myelodysplasia. CD34 and CD117 expression abnormalities are common.
-
Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells.
-
Polyclonal long-term MFGS-gp91phox marking in rhesus macaques after nonmyeloablative transplantation with transduced autologous peripheral blood progenitor cells.
-
Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation.
-
Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction.
-
Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation.
-
Progesterone receptor activity in leiomyomatosis peritonealis disseminata.
-
Prognostic marker analysis in pediatric intracranial ependymomas.
-
Purification and partial characterization of a human hematopoietic precursor population.
-
Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration.
-
Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks.
-
Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy.
-
Rationale and design of the Japan-USA harmonized assessment by randomized, multicenter study of OrbusNEich's combo StEnt (Japan-USA HARMONEE): Assessment of a novel DES platform for percutaneous coronary revascularization in patients with ischemic coronary disease and non-ST-elevation acute coronary syndrome.
-
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).
-
Retroviral vector-mediated gene transfer into umbilical cord blood-derived megakaryocyte and platelet progenitors.
-
Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy.
-
Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials.
-
Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues.
-
Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development.
-
T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates.
-
The In Vitro Differentiation of Human CD141+CLEC9A+ Dendritic Cells from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells.
-
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
-
The effect of aspirin on endothelial progenitor cell biology: preliminary investigation of novel properties.
-
Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma.
-
Unmanipulated or CD34 selected haplotype mismatched transplants.
-
Visible light optical spectroscopy is sensitive to neovascularization in the dysplastic cervix.
-
Keywords of People